Inspired by an almost 10 year old girl with hitherto undiagnosed cognitive
handicap caused by a de novo FOXP1 mutation discovered through whole exome
sequencing. The parents had been
reluctant to consider further children until this diagnosis was made.
Sollis E, Graham SA, Vino A, Froehlich H, Vreeburg M,
Dimitropoulou D,
Gilissen C, Pfundt R, Rappold GA, Brunner HG, Deriziotis P,
Fisher SE.
Identification and functional characterization of de novo
FOXP1 variants provides novel insights into the etiology of neurodevelopmental
disorder. Hum Mol Genet.2016 Feb 1;25(3):546-57.
Abstract
De novo disruptions of the neural transcription factor FOXP1
are a recently discovered, rare cause of sporadic intellectual disability (ID).
We report three new cases of FOXP1-related disorder identified through clinical
whole-exome sequencing. Detailed phenotypic assessment confirmed that global
developmental delay, autistic features, speech/language deficits, hypotonia and
mild dysmorphic features are core features of the disorder. We expand the
phenotypic spectrum to include sensory integration disorder and hypertelorism.
Notably, the etiological variants in these cases include two missense variants
within the DNA-binding domain of FOXP1. Only one such variant has been reported
previously. The third patient carries a stop-gain variant. We performed
functional characterization of the three missense variants alongside our
stop-gain and two previously described truncating/frameshift variants. All
variants severely disrupted multiple aspects of protein function. Strikingly,
the missense variants had similarly severe effects on protein function as the
truncating/frameshift variants. Our findings indicate that a loss of
transcriptional repression activity of FOXP1 underlies the neurodevelopmental phenotype
in FOXP1-related disorder. Interestingly, the three novel variants retained the
ability to interact with wild-type FOXP1, suggesting these variants could exert
a dominant-negative effect by interfering with the normal FOXP1 protein. These
variants also retained the ability to interact with FOXP2, a paralogous
transcription factor disrupted in rare cases of speech and language disorder.
Thus, speech/language deficits in these individuals might be worsened through
deleterious effects on FOXP2 function. Our findings highlight that de novo
FOXP1 variants are a cause of sporadic ID and emphasize the importance of this
transcription factor in neurodevelopment.
Lozano R, Vino A, Lozano C, Fisher SE, Deriziotis P. A de
novo FOXP1 variant
in a patient with autism, intellectual disability and severe
speech and language impairment. Eur J Hum Genet. 2015 Dec;23(12):1702-7.
Abstract
FOXP1 (forkhead box protein P1) is a transcription factor
involved in the development of several tissues, including the brain. An
emerging phenotype of patients with protein-disrupting FOXP1 variants includes
global developmental delay, intellectual disability and mild to severe
speech/language deficits. We report on a female child with a history of severe
hypotonia, autism spectrum disorder and mild intellectual disability with
severe speech/language impairment. Clinical exome sequencing identified a
heterozygous de novo FOXP1 variant c.1267_1268delGT (p.V423Hfs*37). Functional
analyses using cellular models show that the variant disrupts multiple aspects
of FOXP1 activity, including subcellular localization and transcriptional
repression properties. Our findings highlight the importance of performing
functional characterization to help uncover the biological significance of
variants identified by genomics approaches, thereby providing insight into
pathways underlying complex neurodevelopmental disorders. Moreover, our data
support the hypothesis that de novo variants represent significant causal
factors in severe sporadic disorders and extend the phenotype seen in
individuals with FOXP1 haploinsufficiency.neurodevelopmental disorders.
Moreover, our data support the hypothesis that de novo variants represent
significant causal factors in severe sporadic disorders and extend the phenotype
seen in individuals with FOXP1 haploinsufficiency.
No comments:
Post a Comment